MCKECHNIE DUNCAN (EVP, Chief Commercial Officer) sold 13.9% of their position (2.44K shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $1.16M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/6/2026ACC: 0000875320-26-000136
Officer· EVP, Chief Commercial Officer
Since Mar 2026
-2.44K
Net shares
Net seller
$1.16M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.44K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.44K
Price / share
$475.30
Trade value
$1.16M
% of position
13.9%
3/4/2026
17.56K→15.12K
Total
Net shares
−2.44K
Net value
-$1.16M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2026 | S · Sale | −2.44K | $475.30 | $1.16M | 13.9% | 17.56K | 15.12K |
| Total | −2.44K | -$1.16M | ||||||
Derivative Transactions0
No derivative transactions reported